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The reproductively active female squirrel monkey is
characterized by markedly elevated plasma estradiol levels.
Plasma estradiol levels have been reported to be 10 to 30
times that in Old World primates and humans. However, the
exact mechanisms responsible for these elevated estradiol
concentrations have not been fully elucidated. In this
study, two possible mechanisms contributing to elevated
steroid levels were investigated. Investigation of uterine
estrogen receptor binding parameters using the nuclear
exchange method, revealed a uterine receptor concentration
of 228 ±17.6 pmol/1 and a dissociation constant of 2.80
±0.24 nM. Nuclear receptor levels were found to be 46.0
±19.4 pmol/1 with a dissociation constant of 5.42 ±1.92 nM.
Intravenous administration of [3H]-estradiol, followed by-
subsequent collection of urine and feces at 24 h intervals
for a duration of 96 h, revealed that 71.4 % of the
administered radiolabeled estradiol was recovered in the
feces with only a 4.23 % recovery of radiolabeled estrogen
in the urinary pool. Subsequent isolation and
identification of estrogen metabolites by standard
procedures including ion exchange chromatography and TLC,
revealed that sulfate conjugates represented the major
metabolites, with E217S accounting for over 55% of the
total administered dose. Recovery of glucosiduronate
conjugates in both urine and feces was minimal. Subsequent
in vitro liver preparation, that involved characterization
of E2-176 sulfo-transferase activity in cytosol fractions,
revealed that the female squirrel monkey may possess a
sulfotransferase that is specific for estradiol sulfation
at the C-17JS position. This enzyme could in effect reduce
estrogenicity by masking the C-17 hydroxyl group necessary
for activity.
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Traditionally, species of the Old World primates,
including the rhesus and the cynomolgus monkeys, have been
used as models for human reproductive and physiologic
studies. Similarities in physiology of the reproductive
tract as well as similarity of hormonal regulation of
menstrual cycle and pregnancy warranted their use for such
studies. However, due to limited availability and
increasing cost of maintenance, alternative models have
been sought.
The squirrel monkey (5 aimi r i s c iur eus ) , a
representative New World primate, has been investigated as
an alternative model for human reproductive physiology
studies. The New World primates are more adaptable to
laboratory procedures because of their small size.
Besides, the cost for use of these primates is much lower
than for other primates. In addition, several aspects of
their reproductive physiology were applicable to humans.
However, initial investigations showed that in some
aspects, like the reproductive physiology, these primates
differed significantly from Old World primates and humans.
The New World primates examined thus far exhibit an
extreme seasonality of breeding (Dukelow, 1981),
accompanied by fluctuating level of gonadal hormones (Wolf
et al., 1977). Another difference of note is the fact that
the New World primates do not demonstrate a conspicuous
estrus cycle characteristic of lower primates, nor a
detectable menstrual cycle characteristic of higher
primates. Additionally, based upon vaginal cytology
(Hutchinson, 1977) and behavioral observations (Abbot and
Hearn, 1978), and measurement of steroid hormone plasma
levels (Wolf et al., 1977), investigators have demonstrated
that the mean ovarian cycle length is eight to ten days.
This is in sharp contrast to the twenty-eight day menstrual
cycle (Stevens et al. , 1970; Knobil, 1974) characteristic
of the Old World primates and humans. Another difference
revealed is the markedly elevated levels of steroid
hormones. All the New World primates examined thus far are
characterized by high circulating levels of adrenal and
gonadal hormones while maintaining comparatively normal
levels of peptide hormones (Hearn, 1983). In the New World
primates, plasma levels of glucocorticoids (Coe et al.,
985; Setchell et al., 1977) and mineralcoids (Brown et al.,
1970) were found to be elevated as well. Other preliminary
investigations indicated initially that the pathways of
steroid excretion and metabolism may be different in the
New World primates (Setchell, 1977).
The reproductively active female squirrel monkey, a
representative species of the New World primates, has
characteristically elevated circulating levels of
estrogens. The plasma estrogen level has been reported to
be at least 10 to 30 times that in Old World primates and
humans (Dukelow, 1981). Some investigators have even
reported plasma estrogen levels as high as 100 times that
of Old World primates (Wolf et al., 1977). This markedly
elevated estrogen profile presented an enigma to the
biological community, for the estrogen profile did not
appropriately reflect the physiologic state. Despite the
elevated plasma estrogen levels, these primates did not
exhibit any apparent abnormalities in their reproductive
physiology (Diamond et al., 1984). In addition,
examination of target tissues and organs revealed no
adverse changes in the morphology of these structures.
Furthermore, normality of reproductive organs was evidenced
in the fact that mature females were capable of bearing
offspring.
One explanation could be that the estrogen receptor
(ER) binding parameters are altered, leading to end-organ
resistance. Chrousos et al. (1984) have reported a lower
uterine cytosol unoccupied ER level in squirrel monkeys
compared to cynomolgus monkeys. Medlock et al. (1981) have
shown that pharmacological levels of estradiol down
regulate the rat uterine ER. In the squirrel monkey, low
receptor levels could provide normal responses in the
presence of high estradiol levels. Since estrogen binding
to its receptor is dependent upon both hormone and receptor
concentration, lowered levels of either will reduce
responses. Therefore, squirrel monkey ER could have a
lower dissociation constant (Kd). A higher estrogen
concentration would then be needed to saturate the receptor
and lead to tissue responses.
In order to draw an accurate picture of this relation
between steroid binding and physiological responses,
different techniques have been used to determine the total
receptor concentration and Kd in the cytosol and nuclear
compartments. The exchange assays (Anderson et al., 1972a)
carried out at 30-37°C, have allowed measurement of ER
occupied by E2 as well as unoccupied ER.
Apparent resistance to other steroid hormones
including cortisol (Chrousos et al., 1982a), progesterone
(Keller et al., 1979; Chrousos et al. , 1982b) and 1,25-
dihydroxyvitamin D (Eil et al., 1981) has been described
recently in humans and New World primates. In all of these
syndromes characterized by normal physiological function,
elevated plasma steroids concentrations have been
attributed to abnormalities in steroid receptor affinity or
concentration. The response of a cell to a hormone
depends, however, on a number of factors in addition to
receptor affinity and concentration. The currently-
accepted model of steroid action states that the magnitude
of the signal to the cell is dependent upon the
concentration of receptor which in turn is dependent upon
the concentration of receptor, its affinity, and the
concentration of bioactive hormone (Clarke, 1926). As the
concentration of bioactive estrogens is dependent upon its
rate of metabolism, an alternative explanation for high
plasma estrogen levels may be due to a low clearance rate.
Because of the unusual features of estrogen physiology in
this species, a detailed study of the pattern of urinary
and fecal estrogen excretion following [3H]-E2
administration was undertaken.
The elevated plasma estrogen concentrations in the
squirrel monkey are possibly caused by factors that exert
their influence prior to interaction with the intracellular
receptor. The squirrel monkey and other New World primates
might exhibit markedly elevated plasma estrogen levels due
to binding with plasma proteins. When steroids are
released into systemic circulation, they circulate
primarily bound to specific plasma proteins or
nonspecifically to albumin. According to the consensus,
only that fraction that is free and unbound to plasma
proteins is available for the elicitation of characteristic
hormonal response (Clarke, 192 6). In plasma, only a minute
fraction of hormone is free and readily diffuses out of the
capillaries for interaction with target receptors.
Therefore the rate of dissociation or the concentration of
steroid binders in plasma can influence the level of
bioactive steroids.
Previous reports by Musey and coworkers (1982) have
shown that in the squirrel monkey, sulfoconjugates are the
major plasma metabolites. Following intravenous
administration of [3H]-E2/ more than 98% of the
radioactivity in plasma was identified as E217S and
E23,17S. Furthermore, results in the present study show
that these two metabolites are the predominant estrogens
excreted in urine and feces. Combined, these findings
suggest that this species might possess an enzyme system
that is more efficient in the sulfation of estradiol. It
is possible that in the squirrel monkey 17S sulfation of E2
is an adaptive mechanism for reducing estrogenicity. Pack
and Brooks (1974) have postulated that sulfoconjugation may
play a role in the regulation of responsiveness to target
tissues by governing the concentration of free E2. The
presence of relatively high concentrations of estradiol-17-
sulfate in body fluids of the squirrel monkey and its
implications in regulation of E2 responsiveness warranted
the characterization and partial purification of the




Estrogens: A General Overview
Research on estrogens began around 1900 when Halban
(1900) and Knauer (1900) independently implanted rabbit
ovaries into previously ovariectomized rabbits and
concluded that these organs stimulated uterine growth by
secretion of a biologically active substance into the
blood. The estrogens are naturally occurring steroid
hormones that coordinate systemic responses of the female
reproductive physiology. Estrogens are responsible for the
development of female secondary sex characteristics. In
addition, estrogens, in conjunction with other gonadal
hormones, play a pivotal role in the regulation of cyclic
patterns of the female including ovum maturation,
ovulation, and the menstrual flow.
Estrogens belong to a subclass of lipids that contain
a basic skeletal structure of four fused rings referred to
as perhydrocyclo-pentanophenanthrene. All naturally
occurring estrogens are Cis steroids with a characteristic
angular methyl group at position 18, an aromatic A ring,
and a phenolic group at position 3. Because they were the
first estrogens to be isolated, estrone, estradiol-17S, and
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estriol are regarded as the three classical estrogens.
Estradiol-17£ is the hormone normally secreted by ovarian
follicles and since it has the greatest affinity for the
estrogen receptor, it is regarded as the principally active
natural estrogen.
Metabolism of Estrogens
The first indication of estradiol metabolism was
evidenced by the demonstration of quantitative amounts of
estrone in urine following administration of estradiol
(Heard and Hoffman, 1941) . Fishman et al. (1960) further
investigated the in vivo metabolism of [^H]-estradiol and
[14C]_estrone in the human. The [14C]/[3H] (3 :1) ratios for
the estrogens and their metabolites from blood and urine
led the authors to the conclusion that the oxidative
conversion of estradiol-17S to estrone exceeded the reverse
reaction, leading to the conversion of estrone to estradiol
17S. This group also postulated that while estradiol was
the primary estrogen secreted by the ovaries, conversion to
estrone represented the major circulating form of the
estrogen. Diczfalusy (1961) later drew similar conclusions
utilizing various liver tissue preparations.
With the appearance of more sophisticated analytical
tools, detection of other quantitatively important
estrogens was made possible. Marrian (1959) established
the concept of metabolism of estradiol at ring D with the
identification of a 16-oxygenated estrogen in urine and
serum. Fishman et al. (1960) demonstrated the 2-
hydroxylated metabolites of estrogens in urine and plasma
following the intravenous administration of tritiated
estradiol and estrone. In addition, hydroxylations were
shown to occur at the aromatic C-4 position (Gelbke et al.,
1977) and the cyclo-aliphatic positions, 6, 7, 11, 14, 15,
and 18 (Diczfalusy and Lauritzen, 1961; Breuer and Nocke,
1960). Hydroxylations at positions 2 and 16 represent
major pathways of estrogen metabolism in man (Fishman et
al., 1959) .
Conjugation Reactions
Inactivation of estrogens occurs primarily in the
liver, and the inactive metabolites are generally
conjugated as sulfate esters or iS-glucosiduronates (Briggs
and Brotherton, 1970) before excretion in urine. At least
two systems have been described that are active in the
formation of sulfate esters of estradiol. Adams et al.
(1967, 1974) described a sulfotransferase that was specific
for estrogen while Ryan and Carroll (1976), and Gugler et
al.,(1970) independently characterized a sulfotransferase
that is rather nonspecific for 3 6-hydroxysteroids. The
steroid sulfates are formed by the action of a soluble
sulfokinase that uses 3'-phosphoadenosine-5'-phosphosulfate
(PAPS) as the sulfate donor. Glucosiduronates are formed
by the action of a glucuronyl transferase present primarily
in liver microsomes, and uridine diphosphoglucuronic acid
(UDPGA) that serves as the glucosiduronate donor (Barman,
1969). Steroid hormones have also been shown to undergo
conjugation reaction with glutathione (Jellinck et al.,
1965), N-acetylglucosamine (Collins et al., 1968), and
glucose (Layne, 1971) .
In the past, it was believed that the purpose of the
conjugation was to render bioreactive compounds
physiologically less active and more water soluble to
facilitate rapid excretion. However, recent studies have
led to the idea that conjugates, particularly sulfates, may
play a pivotal role in steroid activity. Under normal
conditions, the metabolic clearance rate of estrone
sulfates is less than 10% of that of unconjugated estrone
(Rosenthal et al., 1972). In addition, a number of target
estrogen tissues, including the uterus (Zuckerman and
Hagerman, 1969; Dolly et al., 1972) and the pituitary
(Payne et al. , 1973) contain sulfatases capable of
hydrolyzing the sulfate moiety, thus rendering the estrogen
biologically active. Estrone sulfate may serve as a
transport form of estrogen until reaching its target site
(Ruder et al., 1972). Baulieu and Dray (1963) demonstrated
the direct conversion of estrone sulfate to estradiol
sulfate without prior hydrolysis of the sulfate moiety.
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Upon delivery to the target site, the estrogen sulfate may
be reactivated immediately by sulfatases present in target
tissues.
Patterns of Excretion
The fate of intravenously administered estrogens and
metabolites of estrogen have been extensively studied in
humans and to a lesser extent in subhuman primates. Very
small proportions of steroids are excreted unchanged in the
urine and bile. The bulk undergoes chemical modifications,
mainly oxidative or reductive reactions, followed by
conjugation with either sulfuric or glucosiduronic acids.
in the human, estrogen metabolites are principally
eliminated by way of the kidney. in vivo studies by
Sandberg and Slaunwhite (19 57) demonstrated that following
administration of tritiated estrone and estradiol, more
than 80% of radiolabeled estrogens were eventually
recovered in the urine. Migeon et al. (1959) noted similar
results when [14C]-estrone was administered to human
subjects. Only 1-2% of the estrogens appeared as
unconjugated steroids with 5% as sulfate esters and 33-53%
as glucosiduronates.
Graham et al. (1972) have studied urinary excretion of
estrogen metabolites in the chimpanzee. The free,
unconjugated fraction accounted for approximately 20% of
the total urinary estrogens. Sulfates and
glucosiduronates accounted for 7 and 75%, respectively
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(Graham et al., 1972). In the orangutan, 17% of the total
urinary estrogens was identified as unconjugated estrogens.
Again the glucosiduronates were the major metabolites
(51%), with sulfates representing 34% of the total urinary
estrogens. An interesting feature of urinary metabolites
in apes was the increased excretion of free, unconjugated
estrogens when compared to the urinary excretion of
unconjugated estrogens in women (Crowell et al., 1967) .
However, in apes and women, estrone glucosiduronate was
consistently the major urinary estrogen conjugate (Crowell
et al., 1967; Wright et al., 1978).
Sandberg and Slaunwhite (1965) were the first to
establish the importance of biliary excretion in estrogen
inactivation. They showed that when radiolabeled estradiol
was administered to patients in whom biliary T tube were
inserted, more than 50% of the radiolabeled steroids were
recovered in the bile. In these patients, only 15% of the
radioactivity was accounted for in the urine. Adlercreutz
et al. (19 82) have suggested a concentrating mechanism that
occurs when steroids are transferred from the hepatic cells
to the bile canaliculi, since the concentration of
individual steroids in the bile was shown to be very much
higher than their precursor hormone in plasma. Thus, the
extent to which a steroid is sequestered in bile would
influence its rate of elimination from circulation.
12
Factors modulating sequestration of steroids in bile
are not completely known, but molecular size and structure
of metabolites seem to influence biliary secretion. Musey
et al. (1972) showed that double conjugates of estrogens
such as estriol-3-sulfate-16-glucosiduronate and estradiol-
3-sulfate-17-glucosiduronate are preferentially excreted
into the bile while monoglucosiduronates (Emerman et al.,
1965, Jirku et al., 1971) such as estrone glucosiduronates
and estriol-3-glucosiduronates are excreted primarily in
the urine. In pregnant women, estriol and 16a-
hydroxyestrone are the major estrogens in bile (Adlercreutz
et al., 1964). Estrone metabolites excreted in bile are
predominantly sulfate esters whereas estradiol is a
relatively minor estrogen in bile (Adlercreutz and Martin,
1976) .
Fecal excretion represents a minor route of
elimination of estrogens. Only 1-18% of intravenously
administered estrone and estradiol is excreted in feces
(Sandberg and Slaunwhite, (1957). The estrogens recovered
in feces are unconjugated estrogens, primarily estradiol,
estrone and estriol (Eriksson and Gustafsson, 1971) . in
addition to these three major estrogens, Adlercreutz and
Jarvenpaa (1982) tentatively identified 16a- and 16S-




Extensive biliary excretion of estrogens results in a
prolonged enterohepatic circulation that is responsible for
its delayed clearance in urine and feces. The importance
of this phenomenon was first suggested by Cantarow (1943)
based upon the demonstration in dogs of a high estrogenic
activity of mesenteric blood following instillation of
estradiol into intestinal loops and the high estrogen
excretion into the bile following duodenal administration
of estradiol. The quantitative significance was later
demonstrated by Sandberg and Slaunwhite (19 65) when it was
observed that, although large percentages of radiolabeled
estrogens were excreted in bile, only 10% of the labeled
steroids appeared in the feces. Subsequently, the work of
many investigators showed that most steroids undergo
conjugation by the liver and some return to the circulation
before renal excretion. Other metabolites cross the
membranes of hepatic canaliculi to be excreted in the bile
followed by secretion into the small intestine.
Enterohepatic circulation of estrogen in man has been
extensively reviewed (Sandberg and Slaunwhite, 1957, 1965;
Emerman et al. , 1967; Jirku et al. , 1974). In the
intestine, steroid conjugates are hydrolyzed, reabsorbed by
the gut mucosa, and then are transported back to the liver
for another round of metabolism as described above.
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Factors Affecting Estrogen Metabolism
The pattern of estrogen metabolism and excretion may
be altered by various factors. Zumoff et al. (1968)
demonstrated that men with cirrhosis of the liver excreted
a greater amount of radiolabeled estrogens in urine than
men with relatively normal livers. Urinary excretion of
estriol was also increased in cirrhotic patients (Cameron,
1957). In addition, Hellman et al. (1956, 1970) showed
that following intravenous injection of estradiol in
patients with total biliary obstruction, 48% of the
radioactivity was excreted in 24 h compared to 3 4% in
normal subjects. Moreover, 29% of the radioactivity was
present in the non-glucosiduronate fraction as compared to
only 12% in the normal human. Zumoff et al. (1968) also
reported a variation in the pattern of estrogen metabolism
in men with hypothyroidic conditions and men with breast
cancer. In such patients ring A metabolites of estrone
were decreased while there was an increase in 16a-
hydroxylation (Fishman, 1965).
Changes in intestinal microflora attributable to
antibiotic administration have also been shown to cause
alterations in estrogen metabolism. Alterations in
intestinal microflora affect a number of steroid
modifications attributed to bacteria. These changes
include hydroxylase, dehydroxylase, reductase, and
epimerase activities (Eriksson et al., 1971). These
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alterations result in the excretion of steroids in the
feces that normally would have been excreted in the bile.
Engel (1957) demonstrated that antibiotics reduce the
percentage of radioactive 17S-estradiol excreted in the
urine. Adlercreutz et al. (1976) have also shown that
ampicillin administration to pregnant women reduces the
urinary excretion of endogenous 16-hydroxylated estrogen
but causes an increase in the fecal excretion of both
conjugated and unconjugated estriol.
The metabolism of steroids could likewise be
influenced by hereditary predisposition and by chemicals
that affect their metabolism. Conjugation is also
dependent upon the availability of PAPS and UDPGA that are
in turn related to the nutritional states (Slaunwhite et
al., 1963; Hoskins and Zanecheck, 1968).
Transport of Steroid Hormones
In addition to receptor binding properties, the
response of a cell to a hormone depends as well on factors
that influence steroid dynamics and bioavailability. These
parameters fluctuate as a function of several variables.
One factor that plays a significant role in the
concentration of circulating hormone is the presence of
steroid binding proteins in plasma. Early models of
steroid hormone transport proposed that only the non-
protein bound, i.e., the free steroid hormones were able to
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influence biological activity (Recant and Riggs, 1952) .
However, the affinity of plasma proteins for steroids may
determine the efficacy of the steroid in a biological
system by regulating tissue uptake and metabolism.
Steroid hormones circulate, primarily not in the free
form, but bound nonspecifically to albumin, or specifically
to plasma proteins. The specific binding proteins bind with
a relatively high affinity for their respective steroids:
sex-hormone binding globulin (SHBG) for testosterone and
estradiol; cortisol binding globulin (CBG) for cortisol,
progesterone, and aldosterone; and vitamin-D-binding
protein (DBP) for vitamin D3. In man, approximately 97% of
circulating testosterone is in the bound form with only
about 3% circulating as free testosterone. Of the bound
fraction, over 65% is bound to SHBG with a dissociation
constant of 1.31 nM. Thirty-three percent of circulating
testosterone is bound to albumin (Baird et al., 1969).
Since estradiol has a slightly decreased binding affinity
(Kd=1.40 nM) for SHBG than testosterone, binding to albumin
(40%) is increased relative to SHBG (58%) (Siiteri et al. ,
1982) . This general pattern is mirrored in androgen and
estrogen dynamics in the baboon (Longcope et al., 1988).
The plasma binding capacities for glucocorticoids are
similar. Ninety percent of cortisol is bound to CBG
(Kd=2.20 nM), whereas CBG binds only about 20% progesterone
with 80% bound to albumin (Dunn et al., 1981) .
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Several investigators have studied several aspects of
serum transport and steroid dynamics in New World primates
with the hope of clarifying the nature of the dramatic
differences in hormone levels that characterize this group
of animals (Siiteri et al. , 1982; Chrousos et al., 1982b;
Pugeat et al. , 1984a). The mean SHBG binding capacity of
the New World primates was found to be generally lower than
that of representative Old World primates (Pugeat et al. ,
1984). SHBG of New World primates, however, exhibited a
lower binding affinity than that of Old World primates.
Chrousos et al. (1984) reported CBG binding dissociation of
5.0±2.8 nM in the squirrel monkey while those of the rhesus
monkey and man were 1.3±0.8 and 1.210.6, respectively.
Despite the difference in SHBG binding parameters in this
species, the plasma distribution of testosterone was found
to be similar to that in the Old World primates with only
about 3% circulating as free steroid and 97% bound to
plasma proteins (Pugeat et al., 1984a).
Recently, Chrousos's group (Chrousos et al., 1984a)
investigated CBG binding properties in the squirrel monkey.
They reported major differences in CBG binding parameters
compared to humans and other Old World primates. Not only
were the total and free serum concentration of cortisol
greatly elevated, but there were also variations in CBG
binding capacity and considerable differences in CBG
binding affinity for cortisol. The affinity constants for
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squirrel monkey CBG were roughly 20-60 times lower than
those in Old World primates. CBG binding capacity in the
squirrel monkey was in the range of 150 to 3 00 nM compared
to 15-40 nM in man. Consequently, the plasma free cortisol
levels are 100 to 1000 fold greater in the squirrel monkey
than plasma cortisol levels in humans (Brown et al., 1970).
No exact function has been assigned to plasma binding
proteins as it relates directly to delivery of steroids to
target sites. However, a strong correlation has been
established between metabolic clearance rate (MCR) and the
binding parameters of plasma binding proteins for their
respective steroids. The average MCR for various steroids
varies from 200 to 2000 liters per day, with variation
dictated primarily by the concentration and affinity to
which it is bound to a specific plasma-binding protein.
The specific binding of testosterone and
dihydroxytestosterone to SHBG and cortisol to CBG is
reflected in relatively low MCRs for these steroids. Petra
et al. (1985) have shown that when plasma SHBG was
increased by infusion of SHBG into monkeys, thereby raising
its plasma concentration considerably, the MCR of
testosterone decreased. Unconjugated steroids which tend
to be bound primarily to albumin, have relatively high
MCRs. In humans, cortisol, which is predominantly bound to
CBG, has a MCR of 200 liters per day and testosterone which
is bound to a lower degree to SHBG, has a MCR of 500 liters
19
per day. Androstenedione and progesterone, which are
predominantly bound by albumin, have a MCR of approximately
2000 liters per day (Wang et al. , 1967; Vermeulen, 1986).
In contrast, sulfate conjugates have a greater affinity for
albumin and as a result reflect a lower MCR of about 20
liters per day (Sandberg et al., 1964). Of the conjugate
steroids, sulfate conjugates are cleared from circulation
more slowly than the glucosiduronate conjugates (VandeWiele
et al., 1963) .
Mechanism of Steroid Action
The characteristic effects of estrogen stimulus in
target tissues have been described in detail (Mueller et
al., 1958; Clark et al., 1976). Following administration
of estrogen, a cascade of biological events ensue in target
tissues including hyperplasia and hypertrophies, imbibition
of water, and eventually increased cell division (Mueller
et al., 1958). At the subcellular level, early events
include phospholipid synthesis (Aizaway and Mueller, 1961),
the production of an induced protein (Barnea and Gorski,
1970), an increase in the DNA-dependent RNA polymerase
activity (Gorski, 1964) , and increased nuclear RNA
synthesis (Hamilton et al., 1968). After approximately six
hours, ribonucleic acid accumulation occurs followed by
protein synthesis, and after 24 h, an increased DNA
synthesis is observed. The precise reason for the
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tissue selectivity of estrogen action was, however, unknown
before the discovery of a specific estrogen receptor.
In the early 19 60s, Jensen and coworkers (Jensen and
Jacobson, 1962) made a great contribution to the
fundamental mechanisms of estrogen action. They were able
to show the differential accumulation and retention of
radiolabeled estradiol by the uterus, vagina, pituitary and
other target organs (Jensen and Jacobson, 19 62; Glasscock
and Hoekstra, 1959). Subsequent studies by other
investigators established the protein nature (Toft and
Gorski, 1965) and intracellular localization of estrogen
receptors (Jensen et al. , 1968), the first hormonal
receptors to be isolated and characterized. The estrogen-
binding macromolecule was found to be an intracellular
component of a proteinaceous nature that associated with
the hormone by a strong non-covalent, physic-chemical
attraction (Toft and Gorski, 1966) . The approximate
association constant for estradiol with its respective
receptor is in the range of 109-1012 M"1 at 37°C (Erdos et
al., 1969; Jensen et al., 1968). In its native state,
i.e., unbound to hormone or isolation in the presence of
low KC1, the sedimentation coefficient for the receptor was
reported as 8S with a molecular weight of 23 6,000 daltons
(Erdos, 1968; Korenman, 1968; Korenman and Rao, 1968). The
8S estrogen-binding complex can be dissociated into a 4.5 S
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macromolecule by treatment with 0.3 M or higher
concentration of KCl (Notides and Nielsen, 1974; Korenman
and Rao, 1968) . Upon binding to its respective hormone,
followed by a temperature dependent translocation to the
nucleus (Notides et al., 1975), there is a conformational
change that results in a protein complex with a
sedimentation coefficient of 5S and a molecular weight of
approximately 110,000 daltons (Notides and Nielsen, 1974;
Jensen et al., 1968).
Our current thinking of the biochemical events leading
to a characteristic estrogen action has been influenced
largely by the work of Jensen (1968) and Gorski (1968) . In
1968, they independently proposed the now classical "two-
step" model of steroid hormone intracellular interaction.
According to this model, steroids diffuse into target cells
and bind to cytoplasmic receptors in a strong but
reversible association. Binding of estrogen to its
specific receptor results in a conformational change of the
receptor followed by a temperature dependent translocation
of the "activated" complex to the nucleus. This activated
receptor is now capable of high affinity binding to nucleus
acceptor sites leading to modulation of transcriptional
events.
Recent evidence has accumulated which raises questions
about some aspects of the two-step model. The results of
classical biochemical studies (Clark, 1984) as well as
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recent histochemical reports utilizing autoradiographic
(Stumpf et al., 1966), cytochemical (Nenci et al., 1981)
and immunocytochemical (Govindan, 1980) techniques indicate
that estrogen receptors are exclusively localized in the
nucleus. It has been postulated that the isolation of
cytoplasmic receptors is an in vitro artifact caused by
cellular perturbation during homogenization (Walters et
al., 1981). Notwithstanding these recent findings, the
basic tenets of the classical model of hormone action
remain valid, i.e., gene function is regulated as a direct
consequence of the presence of active steroid hormone
receptor complexes within target cell nuclei.
Receptor-Mediated Resistance
A compensatory increase in steroid hormone production
more often than not accompanies syndromes of end organ
resistance where there is partially or essentially complete
loss of sensitivity to the effects of circulating steroids.
In his initial description of complete testicular
feminization syndrome, Morris (19 53) noted that individuals
with an apparently normal XY karyotype displayed a female
external appearance but with ambiguous internal sex organs.
Subsequently, Wilkins, (1957) demonstrated that these
individuals had a profound resistance to the action of both
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endogenous and exogenous androgens. In addition, plasma
testosterone levels and rates of testosterone production
by the testes were normal or in most cases higher than in
normal men (Wilson and MacDonald, 1978) .
Chrousos et al. (1982b) have also described a similar
syndrome for glucocorticoid resistance in man. This
syndrome is characterized by markedly elevated levels of
plasma cortisol, increased production rates of cortisol,
and elevated adrenocorticotrophic hormone (ACTH) levels
accompanied by hypertensiveness and hypokalemia. However,
there are no evidences of classical symptoms of Cushing's
syndrome. Keller et al. (1979) have described progesterone
resistance in humans. In this syndrome, resistance is
characterized by abnormal endometrial biopsies during
cycles in which the serum patterns of progesterone,
estradiol, follicle stimulating hormone (FSH), and
luteinizing hormone (LH) were shown to be normal.
Administration of exogenous progesterone did not correct
the abnormality. In in vitro studies of these tissues, the
number of receptors in endometrial cytosol was half that of
preparations from normal control subjects. Also a vitamin-
D dependent rickets type II is associated with reduced
nuclear uptake of the vitamin-D receptor complex in skin
fibroblasts cultured from affected individuals (Eil et al.,
1981) . Similar conditions of partial resistance have been
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described for aldosterone (Cheek and Perry, 1958) and for
thyroid hormone (Refetoff et al., 1962, 1967). in the
New World primates, end organ insensitivity to estrogen,
progesterone, and other steroid hormones have
been described, although these conditions are not
accompanied by clinical manifestations of defects (Hearn,
1983; Chrousos et al., 1982a; Chrousos et al. , 1984). In
studies comparing estrogen receptor binding parameters in
the squirrel monkey and the cynomolgus monkey, a
representative species of the Old World primates, Chrousos
et al. (1984a) reported uterine cytosol receptor
concentrations in the squirrel monkey that were a third of
that in the cynomolgus monkey. The progesterone receptor
level in the squirrel monkey was about one-eighth the
receptor level detected in the Old World monkey. However,
the affinity constants were approximately the same in both
Old and New World primates. Glucocorticoid insensitivity
has also been described in the squirrel monkey as well as
other New World primates. Chrousos et al. (1982a), using
cultured skin fibroblasts, showed that similar
concentrations of glucocorticoid receptors in both Old and
New World primates; but a decreased binding affinity for
dexamethasone in the New World species was reported
compared to that in Old World primates.
25
Importance of Steroid Sulfation:
Steroid Sulfates in Steroid Biosynthesis
In the past, sulfation was thought only to be a
prerequisite for rapid excretion. However, increasing
evidence has warranted re-evaluation of this premise. A
role for steroid sulfates in hormone synthesis was first
suggested by the work of Lieberman's group (Calvin et al.,
1963; Calvin and Lieberman, 1964; Roberts et al. , 1961).
These studies pointed out the existence of a pathway for
the direct conversion of cholesterol sulfate to other
sulfated steroids such as pregnenolone sulfate and
dehydroepiandrosterone sulfate. Later Miyazaki et al.
(19 69) demonstrated that estrone sulfate was required for
the conversion of estrone to catechol estrogens. Hobkirk
and coworkers (1978) more recently have shown the
importance of estrone sulfate in 16-hydroxylation of
estrogen in mammalian liver. Payne and Singer (1979) have
concluded that steroid sulfates serve as precursor pools
for gonadal hormone synthesis in man.
Steroid Sulfates in Neoplasia
Abnormal accumulation of steroid sulfates has also
been linked to cancer. The formation of steroid sulfates
by adrenal tumors reported by Baulieu (19 62) and Dao and
Libby (19 69) demonstrated that mammary tumor extracts
exhibited elevated steroid sulfotransferase activity
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compared to normal mammary tissue. Moreover, it was
suggested that the sulfotransferase levels in the tumors
could be correlated with the patient's response to adrenal
ablation (Dao and Libby, 1969). In another in depth study
of steroid transformation by neoplastic human breast, it
was found (Dao et al. , 1972) that malignant breast tumor
tissue contained the enzymes necessary for transforming the
precursor steroid dehydroepiandrosterone sulfate into
estrogens. Furthermore, Dao et al. (1974) have shown that
mammary tumor extracts contain sulfatases capable of
hydrolysis of the sulfate moieties. Since exposure to
estrogen has been implicated in the development of
adenocarcinoma (Henderson et al., 1977), it is reasonable
to suspect that estradiol and estrone sulfates play a role
in the etiology of various cancers of female reproductive
organs.
Properties of Various Sulfotransferases
Gregory and Lipmann (1957) were the first to provide
proof for the existence of specificity of steroid
sulfotransferase activity by the partial resolution of
phenolic sulfotransferase activity from that of
sulfotransferases that catalyze the transfer of a sulfate
group donated by 3'-phosphoadenosine-5'-phosphosulfate
(PAPS) to dehydroepiandrosterone (DHEA) as well as to other
3S-hydroxysteroids. Later, Nose and Lipmann (1958)
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distinguished steroid sulfotransferase activity toward
estrogens and DHEA. Shortly afterwards, Banarjee and Roy
(1966) purified estrogen and DHEA sulfotransferases from
guinea pig liver 70-fold and 20-fold, respectively.
Current evidence indicates that there may be at least
six different steroid sulfotransferases. In 1974, Adams'
laboratory reported the purification of an estrogen
sulfotransferase from bovine adrenal (Adams and Poulos,
1967), ovary (Adams and Chulavatnatol, 1967), and the
placenta (Adams et al., 1974). The enzyme was specific for
estrogens and sulfated only the phenolic hydroxyl group of
these compounds. The pH optimum was found to be between
8.0 and 10.0. The Km of the estrogen sulfotransferase for
PAPS was 37 |XM, and that for estrone was reported to be 15
\IM. A second steroid sulfotransferase described is the 3E-
hydroxysteroid sulfotransferase of rat liver (Ryan and
Carroll 1976), human liver (Gugler et al, 1970), and human
adrenal (Adams & MacDonald, 1979). Using DHEA as
substrate, the 60-fold purified 3S-hydroxysteroid
sulfotransferase exhibited a pH optimum of 5.0, and the Kms
for PAPS and DHEA were 13 (XM and 6 \1M, respectively. It
was specific for the 3£-hydroxysteroids and, unlike the
estrogen sulfotransferase, it exhibited simple Michaelis-
Menten kinetics.
Chen et al. (1977) reported another steroid
sulfotransferase that was specific for bile acids. Upon
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3 5-fold purification from rat liver cytosol, its apparent
Km values for PAPS and taurolithcholate were 8 (J.M and 5 0
H.M, respectively. The pH optimum was reported to be 6.5
with several essential sulfhydryl(SH) groups present in
this 130,000 dalton protein. Recently, Chen et al.(1985)
have purified bile salt sulfotransferase from human liver.
Using glycolithocholate (GLC) as sulfated acceptor, the pH
optimum was 6.5. The Kms for PAPS and GLC were 0.7 \1M and
2.0 \1M, respectively. This sulfotransferase also required
the presence of a sulfhydryl group.
Singer et al. (1976) reported on three
sulfotransferases isolated from rat liver that sulfated
adrenal glucocorticoids. The enzymes were designated
sulfotransferases I, II, and III based on the order of
their elution from a DEAE-Sephadex A-50 column.
Sulfotransferase III appeared to be the 3-6 hydroxysteroid
sulfotransferase characterized by Ryan and Carroll (1976).
Sulfotransferase II was purified approximately 2500-fold
from liver homogenates of female rats. The Kms for PAPS
and cortisol were 6.82 (iM and 6.28 \IM, respectively. A pH
optimum of 6.0 was obtained. Sulfotransferase I was
purified 1250-fold and exhibited a pH optimum of 6.0 using
cortisol as a substrate. The Kms for cortisol and PAPS
were 7.09 [M and 10.6 fiM, respectively. Although these two
enzymes, sulfotransferase I and II, exhibited similar
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properties, they differed greatly in substrate preference,
Km for PAPS, and the response to metal ions. Recently,
Lewis et al. (1981) have also reported the isolation of a
new mineralcorticoid sulfotransferase from the liver of
female rats.
The isolation and characterization of at least six
steroid sulfotransferases that have specific steroid
substrate requirements seem to strongly support the claim
that sulfation is more than a general mechanism of steroid
detoxification. Steroid sulfation may play a role in the






17S-[2,4,6,73H]-Estradiol (E2) (specific activity 104
Ci/mmol) with greater than 98% radiochemical purity was
obtained from Radiochemical Center, (Amersham, U.K.).
Diethylstilbestrol was purchased from Research Plus Steroid
Laboratories Inc. (Denville, NJ). Unlabeled 17£-estradiol,
17a-estradiol, estrone, estriol, DHEA, testosterone, E23S,
and PAPS were all purchased from Sigma Chemical Co. (St.
Louis, MO). All other chemicals used were of analytical
grade.
Animals
Six young non-cycling female squirrel monkeys (Saimiri
sciureus) were obtained from Primate Services, Inc. Miami,
FL. They were housed in temperature (23°C) and humidity
(50%) controlled rooms with a 12 h light: 12 h dark cycle.
Purina Monkey Chow (Ralston Purina Company) and water were
provided ad libitum. Two weeks after arrival, estradiol
was administered (i.m. 10 ug/kg BW once daily for two days)
to three monkeys and vehicle (sesame oil) to the remaining
three monkeys. Uteri were removed using an aseptic
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surgical technique under ketamine/lidocaine anesthesia.
Uteri were immediately frozen in liquid N2 and stored at
-80°C until assay.
RadioiminunoassaY
Circulating levels of estradiol were measured using a
commercially available radioimmunoassay (RIA) kit from ICN
Biomedicals, INC., (Carson, CA) (Abraham, 1975). 6-keto-
estradiol-17S-6-Oxime-BSA was used as the antigen to
generate the antiserum in rabbits. Cross reactivities of
the antibody with other estrogens were as follows: estrone,
20%; estriol, 1.51%; estradiol-17oc, 0.68%. The antiserum
was diluted in MES/gelatin buffer to bind 40-55% of the
[125j]-estradiol derivative. Estradiol concentrations used
to generate the standard curve ranged from 0-3000 pg/ml.
The assay mixture contained 50 (J.1 of undiluted serum
and 500 (J.1 of [125I]-E2. To this, 500 |ll of anti-E2 was
added to all tubes except the non-specific binding (NSB)
tube. Incubations were at 37°C for 90 min. After
incubation, 500 |il of the precipitating solution (goat anti
rabbit gamma globulin) was added to each tube, followed by
centrifugation at 1000 x g for 20 min. The supernatant was
aspirated and the precipitant remaining was counted in a
gamma scintillation counter calibrated for 125I. Results
were calculated using a standard RIA data reduction system.
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Preparation of Subcellular Fractions
Individual homogenates of each uterus were prepared by
two 15 s bursts at setting 6 with a Brinkman Polytron
(Brinkman Instruments, Westbury, NY) in 10 mM Tris-HCl, 1.5
mM EDTA, 1 mM dithiothreitol (DTT) and 10% glycerol, pH 7.4
(TEDG buffer), utilizing 0.1 gram of tissue per 10 ml
buffer. Homogenates were centrifuged at 800 x g for 20
min. in a Beckman J-21 centrifuge. The 800 x g pellet
obtained was designated as crude nuclear pellet. The
supernatants were then centrifuged at 105,000 x g for 1 h
in a Beckman L5-65 ultracentrifuge. The supernatant from
the last step was designated as cytosol and was used in
subsequent assays.
Nuclear Exchange Assay
Specific nuclear estradiol binding sites were assayed
by the method described by Anderson et al. (1972). The
crude nuclear pellets were washed three times with three ml
of the TEDG buffer and each wash was followed by
centrifugation at 800 x g for 10 min. The washed pellet
was suspended in TEDG buffer to a concentration equivalent
to 250 mg protein per ml and gently re-homogenized.
Aliquots (0.25 ml) of this suspension were dispensed into
two series of 6 tubes labeled A and B containing 0.05 ml of
TEDG buffer. Series A contained various concentrations
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(0.75-5.0 nM) of [3H] -E2 and was used to determine the
total amount of [^h]-E2 exchanged. Series B contained the
same concentration of [^H]-E2 as in Series A plus a 100-
fold excess of diethylstilbestrol (DES). The B series was
used to determine the specific [3h]-E2 exchange. The crude
nuclear assay mixtures were incubated with gentle shaking
at 37°C for 30 min. After incubation, 1 ml of ice cold
TEDG buffer was added to the assay tubes, followed by
centrifugation at 800 x g for 10 min. Pellets were washed
three times with TEDG buffer and extracted with 1 ml 100%
ethanol followed by centrifugation at 800 x g for 10 min.
The ethanol extract was added to 5 ml of scintillation
cocktail (Safety Solve, Research Products Inc. Mt. Prospect
ID .
Cytosol Assay:
The cytosol fraction was assayed according to the
method of William and Gorski (1975). Aliquots (0.25 ml) of
this suspension were dispensed into two series of 6 tubes
labeled A and B containing 0.05 ml of TEDG buffer. Series
A contained various concentrations (0.75-5.0 nM) of [^H]-E2
and was used to determine the total amount of [3h]-E2
exchanged. Series B contained the same concentration of
[3h]-E2 as in Series A plus a 100-fold excess of
diethylstilbestrol (DES). The series B was used to
determine the specific [^h]-E2 exchange. Incubation tubes
were placed in an ice water bath for 5-10 min.
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Aliquots 0.25 ml of 60% (v/v) hydroxylapatite (HAP)-
TEDG buffer suspensions were added to each tube and were
left on ice for 15 min. with vortexing at five minute
intervals. The assay tubes were centrifuged at 800 x g for
10 min. HAP pellets were washed four times by suspension
in 1 ml aliquots of the homogenization buffer. This was
followed by centrifugation at 800 x g for 6 min. After
the last wash, 1 ml of 100% ethanol was added to each tube.
The tubes were then placed in a 30°C water bath for 10 min.
The tubes were vortexed followed by centrifugation at 800 x
g for 10 min. Finally, the ethanolic extracts were
transferred to scintillation vials.
Statistical Analysis
The calculation of dissociation constants and [3h]-E2
binding capacities were determined according to the method
of Scatchard (Scatchard, 1949) after subtraction of non
specific binding. The best fit was determined using a
computerized least square analysis. Data groups were
compared using a Student's t test.
In Vivo Metabolic Studies
Six young female squirrel monkeys (Saimiri sciureus)
weighing 0.6-0.7 kg, were quarantined for approximately six
weeks during which time parasites were eliminated. The
animals were subsequently housed in pairs in a temperature-
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and-light controlled room for several weeks before the
studies were begun. Animals were transferred to metabolic
cages and radiolabeled estradiol-172 (75 ^.Ci in 250 nl
saline solution) was administered by femoral injection.
The urine and feces excreted on each of the 4 succeeding 2 4
h intervals were collected.
Separation of Conjugates from the Urine
The preliminary separation of tritium-labeled free
steroids and estrogen conjugates from the urine was
performed using Baker's octadecyl solid phase extraction
system (J.T.Baker, Phillipsburg, NJ). Briefly, each urine
collection was loaded onto the column. Estrogens were
eluted by 2 successive applications of 3 ml methanol
(Morris et al. , 1982). Radioactive content of each was
determined by taking an aliquot of each for scintillation
spectrometry.
Extraction of Radioactivitv from the Feces
Fecal collections were extracted with ethanol using
the Soxhlet extraction apparatus. Extraction procedures
were carried out for 24 h. Ethanolic extracts were
subsequently evaporated followed by resuspension in 3 ml
distilled water. Aliquots of 0.5 ml were taken for
analysis by scintillation spectrometry.
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DEAE-Sephadex Chromatoaranhy
The ethanolic extracts of each 24-h fecal collection
was evaporated to dryness, redissolved in 3 ml of water and
chromatographed on a (60 x 1 cm) DEAE-Sephadex A-25 in a
linear NaCl gradient (0.0-2.0 M) (Hobkirk et al., 1969).
Ten ml fractions were collected, and 0.5 ml aliquots of
each were taken for scintillation spectrometry.
Thin Laver ChromatoaraphY
Following organic partitioning, aliquots of each
sample were chromatographed on thin layer plates (silica
gel) in the following systems: System I benzene/ethyl
acetate (6:4); System II, 10% NH4OH saturated n-butanol.
Unlabeled reference standards were run in separate
channels. Steroids were visualized on the chromatographic
plates by spraying with 2% (v/v) H2SO4 in methanol and then
heating the plates to 100°C for 5-10 min. Chromatographic
mobilities of radiolabeled estrogens were determined by
cutting chromatographic plates into 1 x 3 cm strips and
placing them into scintillation vials for counting. The Rf
values for the reference standards Ei, E2, and E3 in system
I were 0.79, 0.61, and 0.12, respectively. The Rf values
for conjugated estrogen standard E217SS, E23S, and E23,17S
in system II were 0.61, 0.61, and 0.56, respectively.
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Identification of Uncon-iuaated EsCrnapns
Aliquots of radioactive material eluted from the DEAE-
Sephadex columns were extracted 3 times with ether. The
ether extracts were evaporated, and the extract was
chromatographed in system I.
Enzyme Hydrolysis
Further identification of radioactive material eluted
from DEAE-Sephadex eluant fractions was established by
enzyme hydrolysis. Aliquots of pooled radioactive material
eluting between fractions 25-50, were adjusted to pH 5.0
with sodium acetate buffer. Aliquots were then incubated
with S-glucuronidase with 100 units per 10 ml. Radioactive
material eluting in fractions 52-80 was incubated with
phenolsulfatase (12 mg/5 mL) in 0.10 M sodium acetate
buffer, pH 6.0. All incubations were carried out for 24 h
at 37°C. Incubation mixtures were then extracted with
ether. The free estrogens extractable by ether were
identified by TLC as described previously.
Characterization of Cvtosolic E^-IVS Sulfotransferase
Activity
Frozen livers (20 g) were homogenized in one volume of
ice cold 10 mM Tris-HCl buffer pH 7.4, supplemented with 3
mM £ mercaptoethanol, 0.25 mM sucrose. This and all other
preparative procedures were carried out at 0-4°C. The
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homogenates were centrifuged for 20 min at 800 x g. The
supernatant generated was re-centrifuged for 1.5 h at
140,000 x g in a Beckman L-8M 70 ultracentrifuge. The
resulting supernatant, designated cytosol, was the source
of enzyme for all studies, unless otherwise noted.
Standard Sulfotransferase Assay
The assay used in this investigation was adapted from
the published method described by Adams and coworkers
(1974). The E2-17S sulfotransferase was assayed in a
mixture that contained 175 p.1 cytosol, (containing 73 0 p.g
protein), 0.2 mM PAPS, [2,4,6,7 3H]-E2 (106 DPM), 0.008 mM
E2 and 2 mM MgCl2 in a total volume of 250 fil at a pH of
7.4. An assay blank contained all the components of the
assay mixture except for PAPS. After incubation at 37°C
for 20 min, the reaction was terminated by the addition of
1 ml cold methanol. Assay incubation mixtures were stored
overnight at ~20°C to precipitate protein. Following cold
precipitation of proteins, the assay mixture was
centrifuged at 1000 x g and the supernatant decanted.
Identification of estradiol-17S sulfation product was
established by chromatography on DEAE-Sephadex columns (0.9
x 30 cm) with reference [3H]-E2l7S.
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Partial Purification nf F.^-llR fini fni-ransfera.gp
The supernatant fraction obtained from squirrel monkey
liver homogenate was submitted to a precipitation procedure
using ammonium sulfate [(NH4)2SO4] in solid form to arrive
at 50% saturation. The precipitation was allowed to
proceed for 1 h at 4°C. The precipitate recovered by
centrifugation (15,000 x g) was dissolved in a 50 mM Tris-
HC1, 25 mM sucrose, 3 inM g mercaptoethanol, pH 7.9 buffer
The same buffer was used to equilibrate a 1 x 20 cm column
of DEAE-cellulose. Prior to loading onto the column, the
resuspended (NH4)2SO4 precipitant was desalted on a
Sephadex G-25 column. The eluant was concentrated and was
applied to the column. The column was eluted at 1 ml/min
with a linear KCl gradient (0.0-0.5 M). Three ml fractions
were collected. Absorbance was monitored at 280 nm and
each fraction was assayed for estradiol 17S-
sulfotransferase activity. The more active fractions were
pooled and concentrated with Amicon B-15 membranes. The
pH of the extract was then adjusted to 7.9 with 5 N HCl
prior to chromatography on a 5 ml column (1 cm diameter) of
PAP-agarose gel, equilibrated in 50 mM Tris-HCl, 25 mM
sucrose, 3 mM £ mercaptoethanol, pH 7.9. The flow rate was
set to 1 ml/min. The affinity column was washed with five
column volumes of the same buffer and 3.0 ml fractions were
collected. Elution of the adsorbed protein was achieved by
the addition of 0.6 mM PAPS to the washing buffer. After
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adding PAPS, the fractions collected were 0.7 ml in volume.





Determination of Plasma Estradiol Levels
As an index of ovarian cyclicity, plasma E2 levels
were determined prior to estrogen treatment. The mean
plasma E2 concentrations for the six monkeys are presented
in Table 1. In the six squirrel monkeys, the plasma E2
levels ranged from 9.01 to 26.91 pg/ml with a mean plasma
E2 concentration of 17.59±7.85 pg/ml.
Receptor Binding Parameters
Uterine receptor binding parameters in control and E2~
treated squirrel monkeys were determined as described by
Anderson (Anderson et al., 1972). As shown in Table 2,
cytosolic fractions prepared from vehicle-injected animals
exhibited no specific binding of [3H]-E2. Saturable
binding sites for E2 were detected in the crude nuclear
pellets. Analysis of the nuclear binding sites by
Scatchard plots revealed a mean binding capacity of
35.0±21.0 pmol/L with a dissociation constant of 6.29±1.7
nM (Figure 1). In those animals primed with estradiol for
two consecutive days, cytosolic receptor concentrations
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Estrogen Receptor Binding Characteristics in Control















































ND indicates no detection of specific binding and Rt denotes total
receptor
44
Figure 1. Scatchard Plots of [3h]-Estradiol Binding in
Uterine Tissue of Untreated Squirrel Monkeys.
Aliquots of each uterine subcellular fraction
were incubated with various concentrations of
[3H]-estradiol (0.75-5.0 nM) in the presence
and absence of 100-fold excess
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were dramatically increased (Figure 2). In these monkeys,
an average receptor concentration of 228±17.6 pmol/1 was
obtained with an average dissociation constant of 2.80±0.24
nM. The concentration of ER in crude nuclear pellets of
treated monkeys was found to be 4 6.0± 19.4 pmol/1 with a
dissociation constant of 5.42±1.92 nM.
Distribution of Radioactivity in Urine and Feces
Figure 3 shows the distribution of radioactivity in
urine and feces following femoral injection of [3h]-E2. As
shown in the figure, approximately 75% of the administered
radioactive dose was recovered after four days post-
injection. On day 1, 65% of the radioactivity was
excreted, 60% accountable for in the feces and 4% in the
urine. On day 2, total excretion of radiolabeled material
dropped to 5%, almost all of which was recovered in the
feces. Excretion of radioactivity had decreased to about
3% on day 3 and was down to only 2% by the fourth day.
Excretion of radiolabeled compounds after the fourth day
was negligible.
Identification of f-2-Hl -Labeled Estrogen Metabolites in
To identify the individual urinary metabolites
excreted following injection of [3h]-E2, urine samples were
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Figure 2. Scatchard Plots of [3H]-Estradiol Binding in
Uterine Cytosol and Crude Nuclear Pellets of
Estradiol-primed Squirrel Monkeys.
Aliquots of 105,000 x g supernatant prepared
from uterine tissue were incubated with
various concentrations of [3H]-estradiol in
the presence and absence of 100-fold excess
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Figure 3. Distribution of Radioactivity in Urine and
Feces in Squirrel Monkey Following Intravenous
Administration of [3H]-Estradiol.
Daily urine and fecal samples were collected
for a duration of 96 hours following
intravenous administration of [3h]-E2- Total
radioactive recovery was determined for each








fractionated by DEAE-Sephadex chromatography. Seven major
peaks were obtained (Figure 4). Peaks were labeled in
order of their elution from the column. On the basis of
chromatographic profiles, following elution from a DEAE-
Sephadex column, peaks I and II were tentatively identified
as free, unconjugated estrogens. Glucosiduronate
conjugates eluted between fractions 25-40. Peaks V and VI,
eluting between fractions 50-80 corresponded to
monosulfates. Further elution with high NaCl (0.8-2.0 M)
revealed a seventh peak, tentatively identified as a
diconjugate, eluting in fractions 140-155.
Identification of Peaks I and II
The identities of urinary estrogens were established
via TLC and enzyme hydrolysis as shown in Table 3. Organic
partitioning of radioactivity from peaks I and II resulted
in about 98% of the radioactivity extractable by ether.
Thin layer chromatography of ether extracts from peak I and
II in system I yielded Rf values of 0.79 and 0.61,
respectively. These values were identical to those of
authentic Ei and E2 reference standards.
Identification of Peaks III and IV
S-glucuronidase hydrolysis of aliquots of
radioactivity from peaks III and IV, rendered 97% of the
radioactivity extractable by ether. The chromatographic
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Figure 4. Representative DEAE-Sephadex Chromatographic
of 24-Hour Urinary Sample of Squirrel Monkey
Urine samples were collected and concentrated
using a Baker's Ci8 solid phase extraction
system. Concentrated urine was then loaded
onto a DEAE-Sephadex column (1 x 50 cm) . The
column was eluted with a linear NaCl gradient
(0.0-2.0 M) with a total volume of 1000 ml.
Ten ml fractions were collected and 1.0 ml













Fraction # (10 ml/tube)
Table 3
Identification of [3H]-Estrogen Metabolites in Squirrel

















































































* solvent system I: benzene/ethyl acetate (6:4)
solvent sytem II: 10% NH4OH-saturated n-butanol
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mobility in system I of the ether extract derived from peak
III was 0.79 which is identical to that of reference Ei
standard. When chromatographed on thin layer plates in
system I, most of the radioactivity from peak IV migrated
as E2, with an Rf value of 0.61. As a result of these
analyses, peaks III and IV were identified as estrone
glucosiduronate (EiG) and estradiol glucosiduronate (E2G),
respectively.
Identification of Peaks V and VI
After enzyme hydrolysis of Peak V with
phenolsulfatase, 99% of the radiolabeled material was
recovered in the ether extract. TLC (system I) of ether
extracts showed that the labeled material migrated with a
Rf value of 0.79, identical to that of authentic estrone.
Thus, peak V was identified as EiS. Incubation of aliquots
of peak V with phenolsulfatase, resulted in the extraction
of only 2% of the radioactivity by ether. Further
identification of the radioactive material remaining in the
aqueous fraction was achieved by re-chromatography on DEAE-
Sephadex with reference [3h]-E217S. The chromatographic
profile is shown in Figure 5. The elution pattern was
comparable to that of reference [3H]-E2l7S. TLC of the
sample peak in system II gave a simple radioactive
chromatographic profile with an Rf of 0.61, identical to
standard E217S; therefore, peak VI was identified as E217S.
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Figure 5. DEAE-Sephadex Chromatogram of Enzyme Extract
from Peak V.
After incubation with phenolsulfatase,
aliquots of peak V were subjected to ether
extraction. Radioactivity recovered in the
aqueous phase (97%) was applied to a DEAE-














Fraction # (10 ml/tube)
Identification of Peak VII
Thin layer chromatography of aliquots of Peak VII in
system II corresponded in polarity with that of an estrogen
diconjugate. Following incubation with phenolsulfatase and
S-glucuronidase, the majority of the radioactivity remained
in the aqueous phase. Chromatographic mobilities of
radioactivity recovered in the aqueous phase in system II
revealed that the phenolsulfatase-incubated fraction now
behaved as a monosulfate (Rf=0.61) whereas that incubated
with 15-glucuronidase still corresponded to that of the
diconjugate (Rf=0.56). These results showed that at least
one of conjugate groups of the diconjugate was a sulfate
ester. Re-chromatography of the phenolsulfatase-hydrolyzed
fraction on DEAE-Sephadex with reference [^H]-E2l7S
resulted in the elution of a single peak. Peak VII was
identified as E23,17-disulfate.
The relative distribution of the radioactivity in the
individual estrogen metabolites over 4 days is shown in
Table 4. Excretion of unconjugated estrogen was relatively
high on day 1 representing 30.5% of the total urinary
radioactivity. By day 2, urinary excretion of unconjugated
estrogens dropped to only 3%. On days 3 and 4,
unconjugated estrogen represented small, but detectable
amounts of radioactivity. The glucosiduronate fraction,
comprised almost entirely of E]_G and E2G, represented
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Table 4
Excretion of Urinary Estrogen Metabolites Following
Intravenous Administration of [^H]-Estradiol
% of Total Urinary [3H]













































Total% 34.4 15.2 8.40 13.4 11.6 9.30
% of Total Dose





























Total% 1.46 0.65 0.37 0.57 0.50 0.40
55
nearly 24% of total urinary estrogens. Excretion of E]_G
exceeded E2G during the first 24 h, 11.3% versus 7%. On
days 2-4, this excretory pattern of glucuronides was
repeated with only fractional differences in the amount of
EiG and E2G excreted. Sulfated estrogens represented 30%
of the total urinary radioactivity. Over the 4 days, EiS,
E217S and E23,17-diS accounted for 13%, 12%, and 9%,
respectively. Figure 6 represents a cumulative excretion
of labeled metabolites in the urine.
Identification of T3H1-Labeled Metabolites in
Initial separation of fecal metabolites was carried
out by anion exchange (DEAE-Sephadex A-25) chromatography.
Figure 7 shows a representative chromatogram of estrogen
metabolites eluted from DEAE-Sephadex. Radiolabeled
material, representing unconjugated estrogens, eluted early
followed sequentially by the glucosiduronate fractions,
sulfoconjugates, and finally at increased NaCl, a
diconjugate fraction.
Identification of individual peaks was established as
shown in Table 5. Ether extracts of peaks I and II
chromatographed on thin layer plates in system I resulted
in chromatographic mobilities of 0.79 and 0.61
corresponding to that of authentic Ei and E2. Following
incubation of a small portion of peak III with S-
56
Figure 6. Cumulative Excretion of Tritium-labeled
Estrogen Metabolites in Urine of Squirrel


















Figure 7. Representative DEAE-Sephadex Chromatogram of
24-Hour Fecal Extract of Squirrel Monkey.
Fecal samples were collected and concentrated
using Soxhlet extraction system. Concentrated
fecal extracts were then loaded onto a DEAE-
Sephadex column (1 x 50 cm). The column was
eluted with a linear NaCl gradient (0.0-2.0 M)
in a total volume of 1000 ml. Ten ml
fractions were collected and 1.0 ml aliquots













Fraction # (10 ml/tuba)
Table 5
Peak Identification of [3H]-Estrogen Metabolites in Squirrel








































































♦solvent system I: Benzene/ethyl acetate (6:4)
solvent system II: 10% NH4OH -saturate n-butanol
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glucuronidase, 97% of the radioactivity was recovered as
free steroid. Subsequent TLC in System I indicated that
peak III was EiG. Hydrolysis by phenolsulfatase liberated
virtually all of the radioactivity from peak IV as free
steroid, which yielded a chromatographic mobility of 0.79.
A major portion of the radioactivity (98%) of peak V was
not hydrolyzable by incubation with phenolsulfatase.
Analysis of the aqueous fraction by TLC in system II gave
an Rf value of 0.61, also indicative of conjugated estrogen
metabolite. Chromatography of a portion of this aqueous
fraction on DEAE-Sephadex along with standard [3h]-E217S
resulted in the elution of a single peak. Incubation of
portions of peak VI with either S-glucuronidase or
phenolsulfatase did not yield ether extractable radioactive
material. Chromatographic mobilities of the enzymatic
extracts in system II demonstrated that the phenolsulfatase
incubation rendered radioactive material that now migrated
as a less polar component. When the enzymatic extract was
re-chromatographed on DEAE-Sephadex, the radiolabeled
material eluted as a single peak. TLC of an aliquot in
system II gave a Rf value of 0.61, corresponding to E217S.
Estrogen metabolites recovered in fecal extracts are
presented in Table 6 along with the relative amounts of
radiolabeled material contained in each. The unconjugated
fractions were comprised primarily of estrone and
estradiol. On day 1, unconjugated estrogens represented 7%
60
Table 6
Excretion of Fecal Estrogen Metabolites Following
Intravenous Administration of [^H]-Estradiol
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of the total radioactivity recovered in the feces but
decreased to less than 1% by day 2. Fecal excretion of
unconjugated estrogens was undetectable on days 3 and 4.
The principal estrogen excreted in the glucosiduronate
conjugate fraction was EiG. Over four days, estrone
glucosiduronate accounted for about 20% of total fecal
radioactivity with 21% excreted on day 1. The major
monosulfates identified in feces were EiS and E217S.
Minute amounts of radioactivity corresponding to E23S were
detected on days 3 and 4. E217S was the major estrogen
metabolite accounting for about 50% of the fecal
radioactivity on day 1, increasing to a cumulative total of
55 % by day 4. On day 1, EiS represented 6% of the total
fecal radioactivity. During the following days, its
excretion in feces showed some minor fluctuations, but no
significant changes in excretory pattern. The diconjugate
fraction was identified as E23,17-diS. Figure 8 represents
a cumulative excretion pattern of radioactivity in the
feces over the four days.
Optimum Assay Conditions for Estradiol-17S-sulfotransferase
Estradiol-176 sulfation as a function of concentration
of protein obtained from squirrel monkey liver cytosol was
determined. The results are shown in Figure 9. In a one
hour incubation with 0.008 mM E2, the amount of E217S
formed was linear up to protein concentration of 150-820
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Figure 8. Cumulative Excretion of Tritium-labeled
Estrogen Metabolites in Feces of Squirrel
























Figure 9. Effect of Cytosol Concentration on E2-17S
Sulfotransferase Activity.
Incubations were carried out for 20 min. at
37°C with 8 nM estradiol in Tris buffer
containing 0.2 mM PAPS. Each point represents
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jig/ml of. At a maximum protein concentration of 730 mg/ml
more than 60% of the added [3H]-estradiol was converted to
E217S during the 1 h incubation period.
The time course of the sulfoconjugation reaction is
shown in Figure 10. The reaction was linear for over 20
min.
The effect of pH on cytosolic E2-17S sulfotransferase
activity is shown in Figure 11. Using 0.008 mM E2 and 10
mM Tris buffer, a pH optimum of 7.5 was determined.
Other Effects on E9-17S Sulfotransferase Activity
Effect of Cvsteine:
A requirement for a free SH group (s) to achieve
maximum activity in the case of phenol sulfotransferase
(Adams and Poulos, 19 67) has been reported. In order to
assess the dependence of E2 17 S sulfotransferase activity
on the presence of sulfhydryl groups, activity was
monitored at various concentrations of cysteine. The
effect of cysteine on E2-176 sulfotransferase activity is
shown in Figure 12. E217S sulfotransferase activity was
overall enhanced by the addition of cysteine. However, a
cysteine concentration of 5 mM consistently resulted in a
slight decrease in cytosolic E2-176 sulfotransferase
activity.
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Figure 10. E2-17E Sulfotransferase Activity as Function
of Time.
Cytosol was incubated with estradiol using













Figure 11. Effect of pH on E2l7£-Sulfotransferase
Activity.
Cytosol was incubated with 8 nM estradiol in
Tris buffer containing 0.2 mM PAPS. Ionic





































The effect of various metal ions on the activity of
E2-17S sulfotransferase activity (Figure 13) was very
similar to that described for other estrogen
sulfotransferases (Adams et al., 1974). At concentration
of 0.008 mM E2 and 0.2 mM PAPS, Mg2 + activated 17S
sulfation of E2. Ca2 + enhanced the sulfotransferase
activity to a slight extent. Zn2+ was strongly inhibitory
and Co2+ had virtually no effect on E2-176 sulfotransferase
activity at low concentrations, but was inhibitory at
higher concentrations.
Effect of Steroids on Specific Estradiol-178
Sulfotransferase Activity
These studies were carried out to ascertain whether
steroids that inhibited other sulfotransferases affected
17S sulfation of estradiol. As an index of specificity,
test compounds were used at concentrations that gave
inhibitor-to-substrate ratios exceeding those resulting in
strong inhibition of other sulfotransferases. As shown in
the Table 7, at 25 (iM estrone, estradiol-17a, and estriol,
did not inhibit E2-17E sulfotransferase activity, but
actually resulted in a significant increase in 17S
sulfation of estradiol (p_ < 0.005). At a concentration of
25 |IM, DHEA caused a small but significant (p_ < 0.005)
decrease in activity. Testosterone and E23S present in the
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Figure 13. Effect of Metal Ions on E2l7£-Sulfotrans-
ferase Activity.
E2-17S sulfotransferase activity was measured
using the standard sulfotransferase assay at




















Effect of Steroids on Estradiol-1713 Sulfotransferase
Activity in Squirrel Monkey Liver Cytosol
Steroid Enzyme activity observed with steroid at indicated
concentrations (pM) in reaction mixtures
8.0 25.0






a Estradiol-17S sulfotransferase activity was assayed using the standard
enzyme assay with 8 nM estradiol-17B. An activity of 12.6±.013 nmol/min
was determined
b These values represent the mean and standard deviation, n=3..
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assay mixture at equimolar concentrations as E2 resulted in
approximately 30% and 50% inhibition of E2-17 sulfate
production, respectively.
Kinetic Studies
Kinetic studies were conducted with the 140,000 x g
supernatant. To determine the affinity of E2-17£
sulfotransferase for estradiol, estradiol-17S
concentrations were varied while that of PAPS was held
constant at 0.2 mM. Figure 14 shows a double reciprocal
plot of 1/v versus 1/[E2]. The apparent Km determined for
E2-17£ is 5.68 |IM. The apparent Km of E2 - 1 7 £
sulfotransf erase for PAPS was determined at a fixed E2
concentration of 0.008 mM over a range of PAPS
concentration from 0.005 mM-0.6 mM. A double reciprocal
plot of 1/v versus 1/[PAPS] is shown in Figure 15. The
calculated Km for PAPS is 11.6 \m.
Isolation of E?-17£ Sulfotransferase
The specific activities of E2~17£ sulfotransferase at
various stages of purification are shown in Table 8. A
314-fold purification from the cytosolic preparation with
an overall yield of 25% was achieved. Most of the initial
sulfotransferase activity present in the crude homogenate
was recovered in the cytosolic fraction. Ammonium sulfate
72
Figure 14. Lineweaver-Burke Plot of E2-176
sulfotransferase Activity Versus
Concentration of Estradiol-17£.
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Figure 15. Lineweaver-Burke plot of E2-17S Sulfo-




























































[(NH4)2SO4] precipitation (50%) was done, and in general,
the recovery of the enzyme following this treatment was
approximately 76% with a 5-fold purification. Further
purification accelerated the loss of E2 - 1 7 £
sulfotransferase activity, indicating the unstable nature
of the enzyme. Fractionation of the (NH4)2SC>4 precipitate
on a DEAE-Cellulose column is presented in Figure 16. Only
one peak of E2-17S sulfotransferase activity was detected
and the corresponding fractions were pooled and
concentrated for further purification by affinity
chromatography. As shown in Figure 17, most of the
sulfotransferase activity eluted as a single peak after the
addition of 0.6 mM PAPS to the elution buffer. However,
some sulfotransferase eluted during the washing phase.
This low capacity of the affinity column resulted in the
substantial loss of enzyme activity during the final
purification step.
This study describes an assay of the specific E2-17S
sulfotransferase delineating optimum assay conditions.
Also discussed are several important properties of the
enzyme. Subsequent analysis (e.g. kinetic studies,
inhibition and substrate specificity) can be performed
using purified sulfotransferase to allow a more thorough
investigation of the sulfotransferase from squirrel monkey
liver.
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Figure 16. Chromatography of Estradiol-17S
Sulfotransferase on DEAE-Cellulose.
Elution was carried out as described in
Materials and Methods. Protein was assayed by
continuous monitoring at 280 run. Fractions





















Fraction # (3 ml/tube)
Figure 17. Elution Profile of the Estradiol-17& Sulfo-
transferase on Affinity Column, PAP-Agarose.
After elution from a DEAE-Cellulose column
those fractions with highest E2-1715 sulfo-
transferase activity were pooled,
concentrated, and chromatographed on a PAP-
Agarose column (1 x 15 cm) pre-equilibrated in
50 mM Tris-HCl buffer, 25 mM sucrose, 3 ni 15
mercaptoethanol, pH 7.9. Adsorbed protein was





















































Specific estradiol binding sites were identified in
uterine cytosolic and crude nuclear fractions of control
and estradiol-primed female squirrel monkeys. The uterine
estrogen receptor (ER) level determined in the present
study confirms and extends the results of Chrousos et al.
(1984) in the only other reported study of squirrel monkey
uterine ER determination. While these investigators used
ovariectomized animals to eliminate cyclic estradiol and ER
changes, the seasonal breeding pattern of this species
provided us with squirrel monkeys with low serum E2 levels
equivalent to castrates with respect to circulating
estrogen levels. In this study, untreated monkeys had no
detectable specific estradiol binding in cytosolic
fractions, either occupied or unoccupied by estrogen.
Chrousos et al. (1984) using ER assays which measured only
unoccupied cytosol ER, found no detectable specific E2
binders in control animals. These findings demonstrate
that when circulating E2 levels are low, significant
cytosol ER concentrations are not maintained in the
squirrel monkey cytosol. This contrasts with the rat and
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mouse where removal of the ovaries two weeks prior to
determination of receptor concentrations results in lower,
but still substantial levels of cytosol ER compared to
normally cycling animals (Medlock et al., 1981). Results
obtained in this study show that unlike in the cytosol,
specific estradiol binding sites were detected in the crude
nuclear fraction despite low control circulating E2 levels.
Estrogen treatment induced cytosol ER, demonstrating
that the seasonal hiatus in the reproductive cycle does not
abolish ER regulation by E2. However, despite the dramatic
increase in ER levels following estrogen priming, these
levels are relatively low compared to those in Old World
monkeys. Chrousos et al. (1984) found that unoccupied
uterine cytosol ER concentrations in the squirrel monkey
treated with E2 were approximately one-third that in
similarly dosed cynomolgus monkeys. The dissociation
constant for ER binding of E2 under exchange condition for
squirrel monkey cytosol, 2.80±0.24 nM, was essentially
identical to the value of 3.0±l nM reported by Chrousos et
al. (1984) under non-exchange conditions. Since uteri were
removed 24 h after the last E2 treatment, the low value for
nuclear ER concentration, practically indistinguishable
from the control nuclear levels, were expected (Clark et
al., 1976) .
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Data obtained in this study suggest that in the
squirrel monkey, elevated plasma estrogen levels are at
least in part attributable to decreased receptors in target
tissues. In biological systems, generation of estrogenic
response is dependent upon the formation of the receptor-
hormone complex. The interaction of the steroid and its
respective receptor is governed by the classical law of
mass action which states that the formation of the
receptor-ligand complex is dependent upon the concentration
of receptor as well as concentration of the ligand and the
affinity of the receptor for its respective ligand. In
this study, the squirrel monkey's ER affinity for estradiol
was shown to be similar to that of the cynomolgus monkey
(Chrousos et al., 1984). Therefore the products of hormone
concentration times receptor concentration should be
similar and lead to a similar number of ER-complexes, and
therefore similar biological effects. To insure a response
of equivalent magnitude, low receptor concentration in
target tissue would require an increase in plasma steroid
concentration. In the squirrel monkey, it is plausible
that an increased hormone concentration compensates for a
decreased receptor number by increasing receptor occupancy.
The increase in plasma hormone levels would insure an
equivalent biological response.
The squirrel monkey has been extensively used in
experimental research and the results obtained projected to
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the human situation. It has been shown by Wolf et al.
(1977) that plasma estradiol concentrations are very high
compared to that in man and in several Old World primates
(Stevens et al., 1970). In addition, other differences
have been reported. Chrousos and others (1984) showed that
in contrast to Old World species, most of the estrogens in
New World monkeys circulates in the free form, unbound to
plasma proteins. Pugeat et al. (1984) demonstrated that in
the squirrel monkey the concentration and binding affinity
of SHBG for estradiol was decreased compared to that in the
cynomolgus monkey. Despite these variations in steroid
dynamics, the urinary excretion of estrogen conjugates has
not been extensively investigated in the squirrel monkey.
The present studies were therefore undertaken with the dual
objective of increasing existing data on estrogen
metabolism in the squirrel monkey and comparing the pattern
of estrogen metabolism with those in other primate species.
The most obvious feature of the pattern of estrogen
excretion by the squirrel monkey was the small percentage
of radiolabeled steroid recovered in the urine. Urinary
estrogens collected over the 4 days accounted for slightly
less than 5% of the administered radioactive dose. By
contrast, urinary excretion represents the principal route
of elimination in the human. In this study, estradiol and
the 16-keto estrogen comprised the major radiolabeled
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metabolites in both the conjugated and unconjugated
fractions of urine. Estriol, a principal urinary
metabolite in man, was not detected in the urine of the
squirrel monkey in this study. Estrone glucosiduronate,
the principal urinary estrogen in man, represented a small
but significant percentage of the total urinary estrogens.
Most of the estrogens were excreted in the urine
without having been conjugated. In this respect, the
pattern seen in the squirrel monkey more closely resembles
that seen in the baboon (Setchell, 1976). By contrast,
only traces of unconjugated estrogens are detected in human
urine. The very high level of urinary estradiol found in
the squirrel monkey reflects the high plasma free estrogen
concentration in this species.
Perhaps one of the most interesting aspects of urinary
estrogen excretion in the squirrel monkey was the presence
of estradiol-17-sulfate and estradiol-3,17-disulfate in the
urine. These two metabolites accounted for most of the
excreted estrogens. Detection of estradiol metabolites
sulfated at the 1713. position have not been previously
reported in the urine of other subhuman primates. A
possible significance of this pattern of excretion is to
retard the accumulation of toxic concentrations of these
compounds. Masking the 17S hydroxyl group of estradiol
greatly reduces its potency. Recently, Watanabe et al.
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(1988) have reported the detection of estradiol 17-sulfate
in the urine of the human female.
Analysis of fecal excretion yielded striking contrasts
as well. As previously alluded to, fecal excretion seems
to be the major route of estrogen disposal in the squirrel
monkey. This relationship between fecal and urinary
estrogen excretion shows strong contrast with the
experimental findings of Sandberg and Slaunwhite
(1957,1965) who found that approximately 1-18% of
intravenously administered 14C-estradiol was excreted in
the feces of normal human female subjects.
The pattern of estrogens in feces is unique compared
to that found in any other subhuman primate. Of the
estrogens found in the feces, only 7% was unconjugated.
This contrast markedly with the fecal estrogens of other
subhuman primates, 97% of which are unconjugated (Sandberg
and Slaunwhite, 1957). It is also of interest that
glucosiduronate conjugates were detected in the fecal
extracts of the squirrel monkey, whereas in the human
female, no glucosiduronates are found in the feces
(Eriksson and Gustafsson, 1971) . The major fecal
metabolite in the squirrel monkey is estradiol-17-sulfate.
The very high levels of fecal estrogens found in this
animal reflect a greatly reduced enterohepatic circulation
which would tend to increase the time for disposal. In
addition, the unusually elevated levels of conjugated
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estrogens in the feces imply diminished hydrolytic activity
by intestinal microflora. It is also possible that the
high proportion of conjugated estrogens is caused by the
absence of intestinal bacteria. It is well established
that in humans, intestinal microflora are active in
deconjugation of steroid sulfates and glucosiduronates
(Musey et al., 1972). Furthermore, Adlercreutz et al.
(1976) have shown that oral administration of penicillin to
pregnant women, which would greatly affect the intestinal
microflora, results in an increase in the fecal excretion
of both conjugated and unconjugated estriol.
Pack and Brooks (1974) have postulated that estrogen
sulfates play a pivotal role in the regulation of the
responsiveness of target tissue to circulating hormone. The
presence of high levels of E217S and E23,17-diS in the
plasma, (Musey et al., 1982) urine and feces of the
squirrel monkey suggest that sulfoconjugation may serve as
a protective mechanism against estrogen toxicity. This
conjecture seems particularly valid since there are no
known sulfatases capable of converting the conjugate to the
free, active estrogen. While sulfatases capable of
intracellular hydrolysis of phenolic sulfates to yield
bioactive estradiol have been detected, no sulfatases have
been detected that hydrolyze the 17iS sulfate moiety. Thus,
it is likely that although high plasma estrogen levels are
present in the squirrel monkey, steroids circulate
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primarily in a form not capable of eliciting classical
estrogen responses. Therefore, the preferential 17S
sulfation of estradiol could represent an adaptive
mechanism for reducing estrogen exposure.
In the past, investigations have primarily focused on
characterization and purification of sulfotransferases
specific for the 36 hydroxyl or phenolic groups of
steroids. Adams (1967) purified a sulfotransferase from
human adrenal that was specific for estrone, while Singer
(1976) isolated a sulfotransferase specific for the 3£
phenolic group of estradiol. Currently, there is no
referenced literature on a specific estrogen 17£
sulfurylating enzyme system. This is no doubt attributable
to the lack of the detection of estradiol-17£ sulfate
products, although Layne et al. (1970) have reported the
detection of 17S sulfated estrogens in urine of laying hen.
Recently, Watanabe et al. (1988) reported E217S in human
urine. It should be pointed out, however, that this is the
only such report. Because of the potential importance of
17S sulfation of estradiol in regulation of estrogenicity,
it is important that the enzyme system responsible for the
17S sulfation be further investigated.
Few procedures for the purification of hydroxysteroid
sulfotransferase have been reported due to its instability.
Adams and MacDonald (197 9) however did succeed in isolating
a hydroxysteroid sulfotransferase from human adrenals by
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affinity chromatography using a DHA-Sepharose gel. Later
the purification of three rat liver sulfotransferases of
differing specificities were also reported using
conventional chromatographic techniques (Lyons and Jacoby,
1980) . The low recovery of the partially purified enzyme
reported in the present study is similar to that recorded
for other liver sulfotransferases. This low yield limited
further investigation of enzyme properties. Further work
needs to be done on stabilization of the enzyme.
The results obtained in the present study demonstrate
that estradiol-176 sulfurylating activity in squirrel
monkey liver cytosol shares several common characteristics
with previously described steroid sulfotransferases (Adams
and Poulos, 1967; Ryan and Carroll, 1976; Lyons and Jakoby,
1980; Grosso and Way, 1984) . The enzyme is localized in
the cytosol and the pH optimum (7.5) obtained is within the
range reported for other steroid sulfotransferases.
Sulfurylation activity is enhanced by cysteine. The
decrease in 17S sulfation in the presence of 5 mM of
cysteine (Figure 12) was consistently reproducible. The
significance of this effect of cysteine is unknown and
requires further investigation. Although an absolute
requirement for metal ions was not shown, sulfation was
activated by Mg2+ and Ca2+, but was strongly inhibited by
Zn2+ and Co2+-
87
Sulfation of the 17S hydroxyl group of estradiol was
linear with time as well as with the concentration of
protein, but the linearity in relation to the protein
concentration could not be extrapolated through the origin.
This behavior could be explained by low solubility of
estradiol in an aqueous solution in the absence of a
critical amount of protein, or the instability of the
enzyme at high dilutions as reported for other
sulfotransferases (Adams and MacDonald, 1979).
Kinetic studies indicated an apparent Km of 5.68 (IM
for estradiol-17£. This value is within the range the Km
of 3-15 ^M reported for the bovine adrenal sulfotransferase
although, estradiol sulfoconjugation in the squirrel monkey
liver did not exhibit the wave-like kinetics characteristic
of the bovine adrenal sulfotransferase (Adams et al.,
1974). Interestingly, the affinity of the squirrel monkey
liver E2-17S sulfotransferase for estradiol is markedly
greater than that of the rat liver hydroxysteroid
sulfotransferase I (Km of 35 (IM) reported by Lyons et al.
(1980). The rat liver enzyme was also active in sulfation
of the 17S hydroxyl group of estradiol. An apparent Km of
11.6 (IM for PAPS obtained for E2l7£ sulfotransferase is
similar to the reported affinity for PAPS for other
sulfotransferases (Adams et al., 1974).
These investigations indicate very specific steroid
substrate requirements of estradiol-17£ sulfotransferase
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from squirrel monkey liver hornogenate. Unlike the estrogen
sulfotransferase of human adrenal which acts upon the
phenolic group of estradiol but not estrone, this enzyme
system appears to be quite specific for the 176 hydroxyl
group of estradiol. Ring D hydroxyl group in the A
configuration as in epimeric estradiol-17cc and estrone were
not substrates for the enzyme. There were some
similarities in specificities with the several
hydroxysteroid sulfotransferases from rat liver isolated by
Jakoby's group (Lyons and Jakoby, 1980) . The latter
enzymes sulfated estradiol and not estrone and were
reported to catalyze the production of estradiol-17-
sulfate. However, DHEA was the preferred substrate, and
simple alcohols and other steroids were sulfated to a much
greater extent than estradiol. These results suggested
that these hydroxysteroid sulfotransferases may represent
isozymes as predicted by Ryan and Carroll (1976) . The
specific estradiol-176 sulfotransferase of squirrel monkey
liver appears to be well suited to convert a large amount
of estradiol to estradiol-17-sulfate. In cytosol
preparations, estradiol 36 sulfation was minimal. It is
likely that the female squirrel monkey has developed an
enzyme system with a greater specificity toward the 176
hydroxyl group of estradiol to diminish prolonged estrogen
exposure.
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In summary, the results reported in this study concur
with previous findings which suggest that decreased
receptor concentrations are responsible for the elevated
circulating estrogen levels. Furthermore, various aspects
of estrogen metabolism in squirrel monkeys support the
contention that elevated estrogen concentrations are
maintained as a result of a decreased disposal rate.
However, findings in this study also seem to suggest that
increased plasma levels are the cause of decreased target
tissue sensitivity as well as the altered pathways of
estrogen metabolism. Decreased receptor concentration and
variations in estrogen metabolism are possible compensatory
adaptations to greatly elevated plasma estrogen levels. If
alterations of receptor concentration were the cause of
elevated estrogen levels, one would expect decreased ER
concentrations at the site of regulation not at sensory
sites such as the uterus or vagina. MacLusky et al. (1984)
have shown that ER concentrations in the pituitary and the
brain of the squirrel monkey are comparable to that in the
cynomolgus monkey. This observation suggests that the
hypothalamic-pituitary system in the squirrel monkey
functions in the same fashion as in other primate species.
It appears as if the feedback system in the brain and
pituitary regulating estradiol-17£ production and secretion
is set to a higher estradiol output and is less responsive
to negative feedback regulation.
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Furthermore, the altered pathway of estrogen
metabolism may be a protective mechanism for reducing
estrogenicity. Results obtained in this study show an
increased fecal excretion of estrogen metabolites with less
than 5% excreted via the urine. The high fecal excretion
represents a diminished enterohepatic circulation which
would diminish the overall exposure of target tissue to the
effects of estrogens. Excretion via the kidney would
require a longer retention of estrogen metabolites since
elimination would be dependent upon glomerular filtration
rate. Studies of the effects of manipulations of hormone
concentrations on metabolism are needed to determine if
alterations in estrogen metabolism is related to elevated
plasma E2 levels.
Results also suggest that in the squirrel monkey,
sulfation, particularly 17S sulfation, is the preferred
mechanism of estrogen inactivation. This, as well, is
possibly an adaptive mechanism in response to elevated
plasma estrogen levels. Sulfation of estradiol at the 17 S
hydroxyl group diminishes estrogen exposure by abolishing
the possibility of reactivation of the sulfate. There are
no sulfatases that are capable of hydrolysis of the 17£
sulfate moiety. Therefore, although plasma levels of
estrogens are high, the predominance of sulfation at C-176
insures that it circulates in a form not capable of
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generating a characteristic estrogenic response. Moreover,
other results obtained herein suggest that the squirrel
monkey may possess an enzyme system specific for sulfation
of steroids at the 17S hydroxyl group. Further
investigation of E2-17S sulfotransferase activity using the
purified enzyme is necessary to allow a more thorough





1. At basal plasma estradiol-17S concentrations, no
specific estradiol binding sites are detected in
uterine cytosol of the squirrel monkey.
2. Seasonal hiatus in the reproductive cycle does not
abolish the regulation of estrogen receptor levels by
estradiol-17£.
3. Specific estradiol-17£ binding sites are present in
nuclear preparations despite non-cycling levels of
estradiol-17S.
4. Estrogen receptor concentrations obtained in the
present study support reports that cytosol receptor
levels are one-third that in representative Old World
primates.
5. The affinity of the estrogen receptor is not
significantly different from that reported for Old
World monkeys.
6. Patterns of metabolism and excretion of estradiol-17E
in the squirrel monkey are unlike that seen in other
non-human primates.
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7. Fecal excretion is the priniciple route of elimination
of estrogens in the squirrel monkey. This results in
a decreased enterohepatic circulation which greatly
facilitates rapid excretion.
8. The result of in vivo metabolic studies indicate
that sulfation is the primary conjugation mechanism,
with estradiol-17g-sulfate as the major metabolite
(accounting for 55% of the injected radioactivity).
9. Glucosiduronate conjugates of estradiol which
represent the principle urinary metabolites in man and
other primates, accounted for only 26% of the
radiolabeled estrogen excreted by the squirrel monkey.
10. Two metabolites, estradiol-17S-sulfate and estradiol-
36,176-disulfate, not previously identified in the
urine and feces of other sub-human primates,
represented a large percentage of the excreted
tritium-labeled metabolites in squirrel monkey urine
and feces.
11. The enzyme responsible for the specific 1715 sulfation
of estradiol has been characterized in the squirrel
monkey liver cytosol.
12. A 314-fold purification of estradiol-1715
sulfotransferase from squirrel monkey liver was
achieved with a final yield of 25%.
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13. The enzyme system appears to be distinct from the
estrogen sulfotransferase previously described by
Adams et al. (1974) that specifically recognized the
3S-hydroxyl group of estrone and estradiol.
14. Maximum sulfation of the 17S hydroxyl group of
estradiol was obtained at pH 7.5.
15. Estradiol-17S-sulfate formation was enhanced by the
presence of cysteine, Mg2 + and Ca2+, but was inhibited
by Zn2+ and Co2+.
16. Estradiol-17S-sulfate formation was partially
inhibited by 17S hydroxysteroids but not by estrone
and 17oc-estradiol.
17. The apparent Kms of the enzyme for estradiol and
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